Antimicrobial 4-oxoquinolizines
AssigneeEvolva SA
InventorsJutta Heim, Peter Schneider, Patrick Roussel, Daniel Milligan, Christian Bartels, Glenn Dale
Life of this patent
Estimating the term…
Loading patent…
AssigneeEvolva SA
InventorsJutta Heim, Peter Schneider, Patrick Roussel, Daniel Milligan, Christian Bartels, Glenn Dale
Estimating the term…
This invention provides novel 4-oxoquinolizine compounds and their uses for a series of broad-spectrum antibiotics having no cross-resistance to existing or emerging classes of antibiotics. In addition the novel 4-oxoquinolizine compounds are useful against CDC Category A and B pathogens The invention also provides pharmaceutical compositions comprising certain 4-oxoquinolizines in combination with subinhibitory concentrations of polymyxin B against clinical isolates which are resistant to quinolones, carbapenems and other antimicrobial agents.
A pharmaceutical composition comprising a Polymyxin and a 4-oxoquinolizine compound represented by formula (II)
(canceled)
6-7. (canceled)
11-16. (canceled)
18-22. (canceled)
24-29. (canceled)
(canceled)
(canceled)
37-38. (canceled)
40-45. (canceled)
A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein
(canceled)
A compound of formula (V) or a pharmaceutically acceptable salt thereof,
(canceled)
52-67. (canceled)
Dependencies are inferred from the claim text.